Murine interferon-gamma inducible protein-10 (IP-10) secreted by Lactococcus lactis chemo-attracts human CD3+ lymphocytes

Biotechnology Letters

Volumn 31, Issue 11, 2009, Pages 1795-1800

  Villatoro Hernandez, Julio ^a,e,f   Arce Mendoza, Alma Yolanda ^a   Rosas Taraco, Adrian G ^a   Esparza González, Sandra Cecilia ^a   Guzmán López, Santos ^b   Elizondo Omaña, Rodrigo E ^b   Chávez Reyes, Arturo ^c   Saucedo Cárdenas, Odila ^a,d   deOcaLuna, Roberto Montes Oca ^a  

^a UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

^b Medicina UANL   (Mexico)

^c DEPARTAMENTO DE FÍSICA   (Mexico)

^d INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^e UNIVERSITY OF GRONINGEN   (Netherlands)

^f KLUYVER CENTRE FOR GENOMICS OF INDUSTRIAL FERMENTATION   (Netherlands)

Author keywords

Chemotaxis; Human lymphocytes; Murine IP 10

Indexed keywords

CHEMOKINES; CHEMOTAXIS; CYTOKINES; HUMAN CD3; HUMAN LYMPHOCYTES; INTERFERON-GAMMA; LACTOCOCCUS LACTIS; LYMPHOID ORGANS; MURINE IP-10; T LYMPHOCYTES;

ANTIBIOTICS; BIOCHEMISTRY; GENETIC ENGINEERING; GLYCOPROTEINS;

INTERNET PROTOCOLS;

CD3 ANTIGEN; CHEMOTACTIC FACTOR; CYTOKINE RECEPTOR; IP10 MIG RECEPTOR; IP10-MIG RECEPTOR;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CHEMISTRY; CHEMOTAXIS; CYTOLOGY; DRUG EFFECT; HUMAN; LACTOCOCCUS LACTIS; LYMPHOCYTE; METABOLISM; MOLECULAR GENETICS; MOUSE; SEQUENCE ALIGNMENT;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD3; CHEMOTACTIC FACTORS; CHEMOTAXIS; HUMANS; LACTOCOCCUS LACTIS; LYMPHOCYTES; MICE; MOLECULAR SEQUENCE DATA; RECEPTORS, CYTOKINE; SEQUENCE ALIGNMENT;

LACTOCOCCUS LACTIS; MURINAE;

EID: 70350294289     PISSN: 01415492     EISSN: 15736776     Source Type: Journal    
DOI: 10.1007/s10529-009-0081-7     Document Type: Article

References (19)

1. Braat H, Rottiers P, Hommes DW, Huyghebaert N, Remaut E, Remon JP, van Deventer SJ, Neirynck S, Peppelenbosch MP, Steidler L (2006) A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease. Clin Gastroenterol Hepatol 4:754-759.
2. Cho HJ, Shin HJ, Han IK, Jung WW, Kim YB, Sul D, Oh YK (2007) Induction of mucosal and systemic immune responses following oral immunization of mice with Lactococcus lactis expressing human papillomavirus type 16 L1. Vaccine 25:8049-8057.
3. de Ruyter PG, Kuipers OP, de Vos WM (1996) Controlled gene expression systems for Lactococcus lactis with the food-grade inducer nisin. Appl Environ Microbiol 62:3662-3667.
4. Frederick MJ, Clayman GL (2001) Chemokines in cancer. Expert Rev Mol Med 3:1-18.
5. Holo H, Nes IF (1989) High-frequency transformation, by electroporation, of Lactococcus lactis subsp. cremoris grown with glycine in osmotically stabilized media. Appl Environ Microbiol 55:3119-3123.
6. Jenh CH, Cox MA, Kaminski H, Zhang M, Byrnes H, Fine J, Lundell D, Chou CC, Narula SK, Zavodny PJ (1999) Cutting edge: Species specificity of the CC chemokine 6Ckine signaling through the CXC chemokine receptor CXCR3: Human 6Ckine is not a ligand for the human or mouse CXCR3 receptors. J Immunol 162:3765-3769.
7. Kuipers OP, de Ruyter PG, Kleerebezem M, de Vos WM (1997) Controlled overproduction of proteins by lactic acid bacteria. Trends Biotechnol 15:135-140.
8. Loetscher M, Gerber B, Loetscher P, Jones SA, Piali L, Clark-Lewis I, Baggiolini M, Moser B (1996) Chemokine receptor specific for IP10 and mig: Structure, function, and expression in activated T-lymphocytes. J Exp Med 184:963-969.
9. Mierau I, Kleerebezem M (2005) 10 years of the nisin-controlled gene expression system (NICE) in Lactococcus lactis. Appl Microbiol Biotechnol 68:705-717.
10. Nouaille S, Ribeiro LA, Miyoshi A, Pontes D, Le Loir Y, Oliveira SC, Langella P, Azevedo V (2003) Heterologous protein production and delivery systems for Lactococcus lactis. Genet Mol Res 2:102-111.
11. Sambrook J, Fritsch EF, Maniastis T (eds) (1989) Molecular cloning: A laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
12. Soto H, Wang W, Strieter RM, Copeland NG, Gilbert DJ, Jenkins NA, Hedrick J, Zlotnik A (1998) The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3. Proc Natl Acad Sci 95:8205-8210.
13. Steidler L, Rottiers P (2006) Therapeutic drug delivery by genetically modified Lactococcus lactis. Ann N Y Acad Sci 1072:176-186.
14. van Asseldonk M, Rutten G, Oteman M, Siezen RJ, de Vos WM, Simons G (1990) Cloning of usp45, a gene encoding a secreted protein from Lactococcus lactis subsp. lactis MG1363. Gene 95:155-160.
15. van Asseldonk M, de Vos WM, Simons G (1993) Functional analysis of the Lactococcus lactis usp45 secretion signal in the secretion of a homologous proteinase and a heterologous alpha-amylase. Mol Gen Genet 240:428-434.
16. Villatoro-Hernandez J, Loera-Arias MJ, Gamez-Escobedo A, Franco-Molina M, Gomez-Gutierrez JG, Rodriguez-Rocha H, Gutierrez-Puente Y, Saucedo-Cardenas O, Valdes-Flores J, Montes-de-Oca-Luna R (2008) Secretion of biologically active interferon-gamma inducible protein-10 (IP-10) by Lactococcus lactis. Microb Cell Fact 7:22.
17. Wells JM, Mercenier A (2008) Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nat Rev Microbiol 6:349-362.
18. Zavala-Flores LM, Villatoro-Hernandez J, Gamez-Escobedo A, Franco-Molina M, Rangel-Colmenero BR, Villanueva-Olivo A, Gutierrez-Puente Y, de Oca-Luna RM, Valdes-Flores J, Saucedo-Cardenas O (2009) Production of biologically active human lymphotactin (XCL1) by Lactococcus lactis. Biotechnol Lett 31:215-220.
19. Zhou XX, Li WF, Ma GX, Pan YJ (2006) The nisin-controlled gene expression system: Construction, application and improvements. Biotechnol Adv 24:285-295.